| [1] |
Warren S, Gates O . Multiple primary malignant tumors: a survey of the literature and a statistical study[J]. Am J Cancer, 1932,16:1358-1414.
|
| [2] |
Demandante CG, Troyer DA, Miles TP . Multiple primary malignant neoplasms: case report and a comprehensive review of the literature[J]. Am J Clin Oncol, 2003,26(1):79-83. DOI: 10.1097/00000421-200302000-00015.
|
| [3] |
Baba Y, Yoshida N, Kinoshita K , et al. Clinical and prognostic features of patients with esophageal cancer and multiple primary cancers: a retrospective single-institution study[J]. Ann Surg, 2018,267(3):478-483. DOI: 10.1097/sla.0000000000002118.
|
| [4] |
Ferguson R, Archambault A, Simpson D , et al. Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM)[J]. Sci Rep, 2019,9(1):10173. DOI: 10.1038/s41598-019-46665-z.
|
| [5] |
Powell S, Tarchand G, Rector T , et al. Synchronous and metachronous malignancies: analysis of the minneapolis veterans affairs (VA) tumor registry[J]. Cancer Causes Control, 2013,24(8):1565-1573. DOI: 10.1007/s10552-013-0233-x.
|
| [6] |
Shan S, She J, Xue ZQ , et al. Clinical characteristics and survival of lung cancer patients associated with multiple primary malignancies[J]. PLoS One, 2017,12(9):e0185485. DOI: 10.1371/journal.pone.0185485.
|
| [7] |
Tichansky DS, Cagir B, Borrazzo E , et al. Risk of second cancers in patients with colorectal carcinoids[J]. Dis Colon Rectum, 2002,45(1):91-97. DOI: 10.1007/s10350-004-6119-y.
|
| [8] |
Ren Y, Law S, Huang X , et al. Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma[J]. Ann Surg, 2005,242(1):55-63. DOI: 10.1097/01.sla.0000168555.97710.bb.
|
| [9] |
Zhai C, Cai Y, Lou F , et al. Multiple primary malignant tumors—a clinical analysis of 15 321 patients with malignancies at a single center in China[J]. J Cancer, 2018,9(16):2795-2801. DOI: 10.7150/jca.25482.
|
